{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-029614","form_type":"8-K","ticker":"ZBH","cik":"0001136869","company_name":"ZIMMER BIOMET HOLDINGS, INC.","filed_at":"2025-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.017552+00:00","generated_at":"2026-05-26T10:34:59.846544+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zimmer Biomet issues $1.75B in three tranches of notes; special redemption tied to Paragon 28 merger","bullets":["Issued $600M 4.700% notes due 2027, $550M 5.050% notes due 2030, and $600M 5.500% notes due 2035.","Interest payable semi-annually on Feb 19 and Aug 19, commencing Aug 19, 2025.","If Paragon 28 merger not closed by Nov 28, 2025 (extendable to Jan 28, 2026) or agreement terminated, 2030/2035 notes redeemable at 101% plus accrued interest.","2027 notes not subject to special mandatory redemption and will remain outstanding even if merger fails.","Change of control repurchase offer at 101% of principal plus accrued interest for each series."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-029614","json":"https://secwatch.observer/filing/0001193125-25-029614.json","markdown":"https://secwatch.observer/filing/0001193125-25-029614.md","text":"https://secwatch.observer/filing/0001193125-25-029614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525029614/0001193125-25-029614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525029614/d888831d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T10:34:59.846544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e3824d18448a754b109024fae0b5dd52bd7c903","claim":"ZIMMER BIOMET HOLDINGS, INC. incurred senior notes of $600,000,000 with noteholders at 5.500% maturing February 19, 2035.","evidence_excerpt":"On February 19, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) completed its previously announced issuance of $600,000,000 aggregate principal amount of its 4.700% notes due 2027 (the “2027 Notes”), $550,000,000 aggregate principal amount of its 5.050% notes due 2030 (the “2030 Notes”) and $600,000,000 aggregate principal amount of its 5.500% notes due 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2030 Notes, the “Notes”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525029614/0001193125-25-029614-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$600,000,000"},{"label":"Counterparty","value":"noteholders"},{"label":"Rate","value":"5.500%"},{"label":"Maturity","value":"February 19, 2035"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"75414ab24140b6e5fa9032abab5e9b0bb2937dea","claim":"ZIMMER BIOMET HOLDINGS, INC. incurred senior notes of $600,000,000 with noteholders at 4.700% maturing February 19, 2027.","evidence_excerpt":"On February 19, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) completed its previously announced issuance of $600,000,000 aggregate principal amount of its 4.700% notes due 2027 (the “2027 Notes”), $550,000,000 aggregate principal amount of its 5.050% notes due 2030 (the “2030 Notes”) and $600,000,000 aggregate principal amount of its 5.500% notes due 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2030 Notes, the “Notes”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525029614/0001193125-25-029614-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$600,000,000"},{"label":"Counterparty","value":"noteholders"},{"label":"Rate","value":"4.700%"},{"label":"Maturity","value":"February 19, 2027"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"9daad87bc9f6c82dfdfd703956cef2124c02e12c","claim":"ZIMMER BIOMET HOLDINGS, INC. incurred senior notes of $550,000,000 with noteholders at 5.050% maturing February 19, 2030.","evidence_excerpt":"On February 19, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) completed its previously announced issuance of $600,000,000 aggregate principal amount of its 4.700% notes due 2027 (the “2027 Notes”), $550,000,000 aggregate principal amount of its 5.050% notes due 2030 (the “2030 Notes”) and $600,000,000 aggregate principal amount of its 5.500% notes due 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2030 Notes, the “Notes”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525029614/0001193125-25-029614-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$550,000,000"},{"label":"Counterparty","value":"noteholders"},{"label":"Rate","value":"5.050%"},{"label":"Maturity","value":"February 19, 2030"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}